Cardinal Health, Inc. $CAH Stock Position Lifted by Livforsakringsbolaget Skandia Omsesidigt

Key Points

• Livforsakringsbolaget Skandia Omsesidigt increased its stake in Cardinal Health by 287.1% during the second quarter, owning 332,899 shares valued at approximately $55.9 million.
• A series of institutional investors have also significantly boosted their positions in Cardinal Health, with 87.17% of stock now held by these investors.
• Cardinal Health declared a quarterly dividend of $0.5107 per share, with a yield of 1.4% and a payout ratio of 31.63%.

Livforsakringsbolaget Skandia Omsesidigt boosted its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 287.1% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 332,899 shares of the company's stock after purchasing an additional 246,900 shares during the period. Cardinal Health comprises approximately 0.1% of Livforsakringsbolaget Skandia Omsesidigt's holdings, making the stock its 10th largest position. Livforsakringsbolaget Skandia Omsesidigt owned approximately 0.14% of Cardinal Health worth $55,927,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. grew its position in Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock valued at $575,327,000 after purchasing an additional 1,193,983 shares in the last quarter. Northern Trust Corp grew its position in Cardinal Health by 3.5% during the first quarter. Northern Trust Corp now owns 3,143,003 shares of the company's stock valued at $433,012,000 after purchasing an additional 105,154 shares in the last quarter. Wellington Management Group LLP grew its position in Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after purchasing an additional 2,249,241 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Cardinal Health by 4.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company's stock valued at $274,599,000 after purchasing an additional 94,768 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in Cardinal Health by 3.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company's stock valued at $227,877,000 after purchasing an additional 52,714 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts recently commented on CAH shares. Wall Street Zen downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Argus set a $189.00 target price on shares of Cardinal Health in a research note on Friday, August 22nd. Bank of America lifted their target price on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, June 10th. UBS Group reiterated a "buy" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Finally, Morgan Stanley reiterated an "overweight" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Cardinal Health has an average rating of "Moderate Buy" and an average target price of $165.93.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $150.45 on Tuesday. The firm has a market capitalization of $35.93 billion, a PE ratio of 23.33, a price-to-earnings-growth ratio of 1.29 and a beta of 0.73. The company's fifty day moving average price is $154.16 and its two-hundred day moving average price is $148.08. Cardinal Health, Inc. has a 52-week low of $106.54 and a 52-week high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. During the same quarter in the prior year, the firm earned $1.84 EPS. The firm's quarterly revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.4%. Cardinal Health's dividend payout ratio is 31.63%.

Insider Buying and Selling at Cardinal Health

In related news, insider Jessica L. Mayer sold 38,078 shares of the company's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the transaction, the insider owned 48,457 shares in the company, valued at $7,211,370.74. This represents a 44.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Ola M. Snow sold 28,151 shares of the company's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the transaction, the insider owned 15,431 shares in the company, valued at approximately $2,298,293.14. This trade represents a 64.59% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock worth $40,489,525 over the last quarter. Corporate insiders own 0.09% of the company's stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.